JRCT ID: jRCT2031210422
Registered date:12/11/2021
Survey of proper use and occurrence of hyperkalemia after administration of MINNEBRO tablets in patients with hypertension - EBM Provider Cohort Study-
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | hypertension |
Date of first enrollment | 01/04/2008 |
Target sample size | 15000 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Conduct serum potassium testing,, Development of hyperkalemia |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Prescription of MINNEBRO tablets has commenced during the enrollment period (May 13, 2019 to May 31, 2023). The diagnosis of hypertension exists on the same month as the date of the first prescription of this drug during the enrollment period. The date of the earliest medical record after the start date of the data period is 180 days or more prior to the date of the first prescription of this drug. |
Exclude criteria | none |
Related Information
Primary Sponsor | Matsuoka Yomei |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Contact for GPSP |
Address | 3-5-1,Nihonbashi Honcho,Chuo-Ku,Tokyo Tokyo Japan 103-8426 |
Telephone | +81-3-6225-1059 |
contact_gpsp@daiichisankyo.co.jp | |
Affiliation | Daiichi Sankyo Co.,Ltd. |
Scientific contact | |
Name | Yomei Matsuoka |
Address | 3-5-1,Nihonbashi Honcho,Chuo-Ku,Tokyo Tokyo Japan 103-8426 |
Telephone | +81-3-6225-1059 |
contact_gpsp@daiichisankyo.co.jp | |
Affiliation | Daiichi Sankyo Co.,Ltd. |